Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 155
Filter
1.
Cell Mol Biol (Noisy-le-grand) ; 55(2): 89-95, 2009 Jul 01.
Article in English | MEDLINE | ID: mdl-19656456

ABSTRACT

Protoporphyrinogen oxidase is the penultimate enzyme in the haem biosynthetic pathway. In this study, the expression of protoporphyrinogen oxidase in a variety of human organs has been documented by immunohistochemical means at the light microscopy level in order to shed light on its inter- and intra-organ distribution. The expression varied amongst organs and the various cell types within an organ. The pattern of staining generally reflected presumed metabolic functionality and haem demand. Strongest staining was noted in hepatocytes, proximal convoluted tubules of the kidney, serous cells of the peribronchial gland in the lung, parietal cells of the stomach, tips of the villi in the small intestine and interstitial cells of the testis. Our results suggest that there are some significant sites of haem synthesis in addition to the liver and bone marrow, and should be borne in mind in studies related to haem or porphyrin dynamics and flux.


Subject(s)
Protoporphyrinogen Oxidase/metabolism , Female , Gastric Mucosa/metabolism , Heme/biosynthesis , Humans , Immunohistochemistry , Intestinal Mucosa/metabolism , Kidney Tubules, Proximal/metabolism , Liver/metabolism , Lung/metabolism , Male , Ovary/metabolism , Placenta/metabolism , Pregnancy , Testis/metabolism
2.
Br J Dermatol ; 149(6): 1266-9, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14674906

ABSTRACT

BACKGROUND: Porphyrinogens are the obligate intracellular precursors of haem. These compounds are, however, unstable and are easily oxidized to the corresponding porphyrins, which are the form in which they are usually measured in the laboratory. A substantial enterohepatic cycling of porphyrins has been shown. Administration of oral activated charcoal, by interrupting this cycle, may reduce plasma and urine porphyrin levels in patients with some forms of porphyria. The effect of charcoal in subjects with variegate porphyria (VP) has not been reported. OBJECTIVES: To determine the clinical and biochemical effects of the administration of oral activated charcoal in patients with VP. METHODS: Oral activated charcoal was administered to eight subjects with VP. Clinical activity was assessed by skin lesion counts fortnightly for 6 weeks, 6 weeks after cessation of therapy, and during a subsequent 6-week control period during which no charcoal was taken. Urine and plasma porphyrins and urine precursors were measured by standard techniques. RESULTS: Treatment resulted in a significant increase in skin disease, urine and plasma porphyrins. CONCLUSIONS: Oral charcoal administration results in a paradoxical aggravation of VP, suggesting a complex and as yet undefined interaction of hepatic porphyrin metabolism and bowel porphyrin reabsorption. Oral sorbents should not be prescribed to subjects with VP.


Subject(s)
Charcoal/administration & dosage , Porphyrias, Hepatic/drug therapy , Administration, Oral , Adolescent , Adult , Aminolevulinic Acid/blood , Aminolevulinic Acid/urine , Analysis of Variance , Female , Humans , Male , Porphobilinogen/blood , Porphobilinogen/urine , Porphyrias, Hepatic/metabolism , Porphyrias, Hepatic/pathology , Porphyrins/blood , Porphyrins/urine , Prospective Studies , South Africa , Treatment Failure
3.
Cell Mol Biol (Noisy-le-grand) ; 48(8): 853-9, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12699243

ABSTRACT

A number of factors, including increased iron stores and alcohol consumption, are known to be associated with the development of porphyria cutanea tarda (PCT) in susceptible individuals. Recent reports have described a significant association between inheritance of the C282Y and H63D mutations in the HFE gene, associated with genetic hemochromatosis (GH) and PCT. A strong association between hepatitis C virus infection and PCT has also been demonstrated, while case reports record a link between human immunodeficiency virus (HIV) and PCT. We have investigated the frequency of these factors in a racially-mixed population of patients with PCT in Cape Town, South Africa. 57 patients with PCT drawn from three ethnic groups were screened for the presence of the C282Y and H63D mutations linked to GH, and the prevalences were compared with corresponding healthy control populations. The seroprevalence of markers for HCV, hepatitis B (HBV) and HIV infection were examined in 28 of these. In the control populations, we found that both the C282Y and H63D mutations are highly prevalent in South Africans of European origin. In a population of mixed or Asian origin, the C282Y mutation is very rare whereas the H63D mutation is common. Neither mutation was encountered in any African subject. Both mutations are associated with PCT, but the association is dependent on the ethnic origins of the population to which the patient belongs. In contrast to other studies, HCV infection is numerically unimportant in PCT in our patients. HIV infection is increasingly encountered in our patients with PCT, but the strength of the association cannot be determined in view of the high background prevalence of HIV infection in some sectors of the South African population. The contribution of specific risk factors may be heavily dependent on the population from which patients are drawn, and care should be taken in extrapolating from observations in one racial or geographic population to any other.


Subject(s)
Histocompatibility Antigens Class I/genetics , Membrane Proteins/genetics , Mutation , Porphyria Cutanea Tarda/etiology , Porphyria Cutanea Tarda/genetics , Alleles , Female , Genetics, Population , HIV Infections/complications , Hemochromatosis Protein , Hepatitis B/complications , Hepatitis C/complications , Heterozygote , Homozygote , Humans , Male , Porphyria Cutanea Tarda/virology , Risk Factors , South Africa
4.
Mol Genet Metab ; 73(1): 91-6, 2001 May.
Article in English | MEDLINE | ID: mdl-11350188

ABSTRACT

Variegate porphyria is an autosomal dominant disorder of haem metabolism resulting from reduced levels of the penultimate enzyme in the pathway, protoporphyrinogen oxidase. Here we investigate the molecular basis of variegate porphyria in four non-R59W South African families. We report the identification of the first mutation in the protoporphyrinogen oxidase gene in a black South African individual (V290M). In addition, we document three further mutations, a missense mutation (L15F), a deletion followed by a substitution [c769delG;770T > A], and a nonsense mutation (Q375X), in individuals of European or mixed ancestry. Our data provide further evidence of genetic heterogeneity in South Africa.


Subject(s)
Oxidoreductases Acting on CH-CH Group Donors , Oxidoreductases/genetics , Porphyrias, Hepatic/genetics , Adult , Base Sequence , Child , Codon, Nonsense , DNA/chemistry , DNA/genetics , DNA Mutational Analysis , Family Health , Female , Flavoproteins , Genetic Heterogeneity , Humans , Male , Mitochondrial Proteins , Molecular Sequence Data , Mutation , Mutation, Missense , Polymorphism, Single-Stranded Conformational , Porphyrias, Hepatic/enzymology , Porphyrias, Hepatic/pathology , Protoporphyrinogen Oxidase , Sequence Deletion , Sequence Homology, Nucleic Acid , South Africa
5.
S Afr Med J ; 91(1): 61-5, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11236301

ABSTRACT

OBJECTIVES: To determine whether portal hypertension in the absence of liver disease contributes to changes in renal function and renal sodium and water handling. METHODS: Nine patients with extrahepatic portal vein thrombosis (PVT) with normal liver function and histology were compared with 9 matched healthy control subjects. All underwent standard measurements of glomerular filtration rate and effective renal blood flow using inulin and paraaminohippuric acid (PAH) clearances, respectively. Sodium excretion and renin and aldosterone levels were studied before, during and after an intravenous saline infusion. RESULTS: At baseline there were no differences in inulin clearance, PAH clearance, fractional excretion of sodium and free water excretion. During and after the saline infusion both groups showed a significant increase in sodium excretion with a reduction in water excretion, while the PAH and inulin clearances remained unchanged. Although aldosterone and renin levels both fell after the infusion, aldosterone levels were significantly lower in the PVT group. There were no other significant differences between the PVT and control groups. CONCLUSION: Renal function and sodium and water handling were comparable in healthy controls and patients with PVT. It is unlikely that portal hypertension alone plays a significant role in the impaired ability to excrete sodium and water in patients with liver cirrhosis.


Subject(s)
Glomerular Filtration Rate , Portal Vein , Renal Blood Flow, Effective , Sodium/metabolism , Thrombosis/complications , Water-Electrolyte Imbalance/etiology , Water-Electrolyte Imbalance/metabolism , Adult , Aldosterone/metabolism , Case-Control Studies , Creatinine/metabolism , Female , Humans , Inulin/pharmacokinetics , Kidney Function Tests , Male , Metabolic Clearance Rate , Renin/metabolism , Time Factors , Water-Electrolyte Imbalance/physiopathology , p-Aminohippuric Acid/pharmacokinetics
6.
J Gastroenterol Hepatol ; 15(11): 1298-306, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11129225

ABSTRACT

BACKGROUND: Neutrophil function has been reported to be abnormal in patients with cirrhosis. In order to evaluate the relative contribution of hepatocellular dysfunction and portalsystemic shunting of blood to these abnormalities, neutrophil function was studied in 18 patients with cirrhosis and portal hypertension. Nine patients, with extrahepatic portal hypertension (EPH) caused by portal vein thrombosis, who had no clinical, biochemical or histologic evidence of liver disease were also studied. METHODS: Superoxide generation, phagocytosis, degranulation, leukotriene B4 release, candidacidal activity and quantitative and qualitative expression of the cell surface adhesive marker CD11b/CD18 were measured in these patients as well as in age- and gender-matched controls. RESULTS: Patients with cirrhosis were found to have a small but statistically significant decrease in the expression of the CD18 component of MAC1 in N-formyl-methionyl-leucyl-phenylalanine-stimulated neutrophils (P = 0.04). No significant differences were found between either of the two patient groups and the control group for any of the other parameters of neutrophil function tested. CONCLUSIONS: These were unexpected findings in the light of data published elsewhere, which indicate impaired neutrophil function in patients with cirrhosis. The study suggests that patients with stable, uncomplicated cirrhosis and patients with EPH have normal neutrophil function.


Subject(s)
Hypertension, Portal/immunology , Liver Cirrhosis/immunology , Neutrophils/physiology , Adult , Aged , CD11 Antigens/metabolism , CD18 Antigens/metabolism , Female , Humans , Hypertension, Portal/physiopathology , Leukotriene B4/metabolism , Liver Cirrhosis/physiopathology , Macrophage-1 Antigen/metabolism , Male , Middle Aged , Peroxidase/metabolism , Phagocytosis , Superoxide Dismutase/metabolism
7.
S Afr Med J ; 90(9): 880-3, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11081139

ABSTRACT

INTRODUCTION: Liver transplantation has evolved from an experimental procedure to being the treatment of choice for many patients with end-stage liver disease, and is performed on a routine basis in most major centres throughout the world. However, certain situations peculiar to developing countries have a major impact on liver transplant programmes in these countries. We present the results of the liver transplant programme in Cape Town. PATIENTS AND METHODS: All patients undergoing orthotopic liver transplantation at Groote Schuur Hospital and Red Cross War Memorial Children's Hospital were included in this report. Standard surgical techniques were used for procuring the donor liver, the recipient hepatectomy and the subsequent implantation of the liver. All patients received standardised peri-operative management; in particular, the immunosuppressive protocol consisted of cyclosporin, steroids and azathioprine. Since October 1988, 83 patients have undergone 89 orthotopic liver transplants. There were 44 adults and 39 children, the age range being from 6 months to 56 years. The commonest indications for hepatic transplantation in adults included cryptogenic cirrhosis, auto-immune hepatitis and primary sclerosing cholangitis. In children biliary atresia was the commonest cause of liver failure. RESULTS: Of the 81 patients transplanted, 50 are alive and well with follow-up ranging from 2 months to 9.5 years. The cumulative graft survival rate was 72% at 1 year and 61% at 5 years. Six patients have undergone re-transplantation and 4 patients have had combined liver/kidney transplants. De novo hepatitis due to hepatitis B virus (HBV) has occurred in 8 patients following transplantation. Subsequent investigation has shown that 5 of the donors of these livers were hepatitis B core antibody (HBcAb)-positive, while information on the remaining 3 was not available. Tuberculosis (TB) has been a significant problem in 4 patients, with 2 deaths precipitated by anti-TB drug-induced hepatitis. Post-transplant lymphoproliferative disorder was also responsible for significant postoperative morbidity. CONCLUSION: Orthotopic liver transplantation has been established at Groote Schuur Hospital as the treatment of choice for selected patients with chronic end-stage liver disease. However, hepatitis B and TB appear to present a problem. The particularly high prevalence of HBV carrier status in our donor population may necessitate the use of living donors in the future.


Subject(s)
Liver Transplantation , Outcome Assessment, Health Care , Adolescent , Adult , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Liver Transplantation/statistics & numerical data , Male , Middle Aged , Postoperative Complications , South Africa , Survival Analysis
8.
Mol Genet Metab ; 69(4): 323-30, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10870850

ABSTRACT

Variegate porphyria is an autosomal dominant disorder of heme metabolism which results from decreased activity of the enzyme protoporphyrinogen oxidase. Clinically, the disease manifests postpubertally and is characterized by photocutaneous sensitivity and/or acute neurovisceral crises. However, in homozygous variegate porphyria, onset of the disease usually occurs in infancy with severe skin manifestations. The molecular basis of variegate porphyria in two severely affected probands in two South African families is described. Mutation detection included combined SSCP-heteroduplex analysis followed by direct sequencing. The unrelated probands both had the common R59W mutation while the other lesion was Y348C or R138P (both novel mutations), causing homozygous variegate porphyria.


Subject(s)
Oxidoreductases Acting on CH-CH Group Donors , Porphyrias, Hepatic/genetics , Adult , Amino Acid Substitution , Child , DNA/chemistry , DNA/genetics , DNA Mutational Analysis , Family Health , Female , Flavoproteins , Genotype , Heteroduplex Analysis , Homozygote , Humans , Male , Mitochondrial Proteins , Molecular Sequence Data , Mutation , Oxidoreductases/genetics , Pedigree , Polymorphism, Single-Stranded Conformational , Porphyrias, Hepatic/enzymology , Porphyrias, Hepatic/pathology , Protoporphyrinogen Oxidase , South Africa
9.
J Med Virol ; 61(1): 52-8, 2000 May.
Article in English | MEDLINE | ID: mdl-10745232

ABSTRACT

GB virus-C and the hepatitis G virus (GBV-C/HGV) are variants of the same positive sense RNA flavivirus, initially thought to be associated with hepatitis. The tissue tropism of GBV-C/HGV in normal subjects has not been evaluated to date using an extended tissue spectrum. Therefore, the sites of GBV-C/HGV replication were investigated in serum and twenty-three tissues collected during post-mortem examination of four apparently healthy individuals who died accidental deaths, who were infected with GBV-C/HGV. All were anti-HIV and anti-HCV negative and three out of four were HBsAg negative. Tissues were collected carefully to prevent cross contamination. A highly strand-specific RT-PCR assay was employed for the detection of either GBV-C/HGV positive strand RNA (virion) or negative strand RNA (replicative intermediary). Strand specificity of the RT-PCR assay was assessed with synthetic positive-and negative strand GBV-C/HGV RNA generated from a plasmid, using T7 and T3 RNA polymerases. The spleen and bone marrow biopsies were found to be uniformly positive for both negative-and positive strand GBV-C/HGV RNA. In addition, one cadaver was positive for both RNA strands in the kidney, and another positive for both in the liver. No negative strand RNA was detected in the following: brain, muscle, heart, thyroid, salivary gland, tonsil, lung, lymph nodes, gall bladder, pancreas, oesophagus, stomach, small bowel, large bowel, adrenal gland, gonad, aorta, skin and cartilage. This preliminary study concludes that GBV-C/HGV is a lymphotropic virus that replicates primarily in the spleen and bone marrow.


Subject(s)
Bone Marrow/virology , Flaviviridae/physiology , Spleen/virology , Virus Replication , Adult , Female , Humans , Male , Middle Aged , Organ Specificity , RNA, Viral/analysis , Reverse Transcriptase Polymerase Chain Reaction/methods
10.
J Med Virol ; 59(1): 52-9, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10440808

ABSTRACT

GB virus C/hepatitis G virus (GBV-C/HGV) has been characterised as a novel flavivirus, and to date three known genotypes have been cloned. Greater genetic variation of GBV-C/HGV has been demonstrated in West African isolates, but no major deletions have been shown in the 5' non-coding region (NCR). The 5'NCR regulates protein translation via an internal ribosomal entry site (IRES). We cloned, sequenced, and analysed a 344-bp polymerase chain reaction (PCR) product, representing >60% of the 5'NCR, from 32 GBV-C/HGV PCR-positive volunteers. Wild-type virus amplicons were detected in all samples. However, 5/32 (15.6%) also amplified another fragment of between 205 and 231 bp. Sequence analysis showed all cloned PCR fragments to be GBV-C/HGV-specific. A typical deletion of 113-131 bp with minor variation was detected in isolates generating the smaller bands. RNA secondary structure analysis showed the deletions to be over domains II and III. This finding suggests that nucleotides 303-444 may be non-essential for 5'NCR functioning. Phylogenetic analysis demonstrated a novel fourth South African genotype, distinct from genotypes 1-3 with DNA distances of >0.1000. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) values for the wild-type and mutant samples were normal. This study documents the first major deletion in the 5'NCR of GBV-C/HGV, and suggests that bases 303-444 may not be essential for viral replication and ribosomal entry. A fourth GBV-C/HGV genotype appears to predominate in South Africa.


Subject(s)
Flaviviridae/genetics , Gene Deletion , Hepatitis, Viral, Human/virology , 5' Untranslated Regions , Base Sequence , Blotting, Southern , Cloning, Molecular , DNA, Complementary/genetics , Flaviviridae/classification , Flaviviridae/isolation & purification , Genotype , Humans , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction , RNA, Viral/genetics , RNA, Viral/isolation & purification , Sequence Analysis, DNA , South Africa
11.
Carcinogenesis ; 20(5): 817-24, 1999 May.
Article in English | MEDLINE | ID: mdl-10334199

ABSTRACT

Fumonisin B1 (FB1) is a carcinogenic mycotoxin produced by the fungus Fusarium moniliforme in corn. Feeding of FB1 to rats causes acute liver injury, chronic liver injury progressing to cirrhosis, and sometimes terminates in hepatocellular carcinoma or cholangiocarcinoma. This study describes the histolopathology and changes in gene expression in the rat liver during short-term feeding of FB1. Male Fischer rats were fed either FB1 250 mg/kg or control diet, and were killed weekly for 5 weeks. FB1 caused a predominantly zone 3 'toxic' liver injury, with hepatocyte death due to necrosis and apoptosis. Hepatocyte injury and death were mirrored by hepatic stellate cell proliferation and marked fibrosis, with progressive disturbance of architecture and formation of regenerative nodules. Despite ongoing hepatocyte mitotic activity, oval cell proliferation was noted from week 2, glutathione S-transferase pi-positive hepatic foci and nodules developed and, at later time points, oval cells were noted inside some of the 'atypical' nodules. Northern blot (mRNA) analysis of liver specimens from weeks 3 to 5 showed a progressive increase in gene expression for alpha-fetoprotein, hepatocyte growth factor, transforming growth factor alpha (TGF-alpha) and especially TGF-beta1 and c-myc. Immunostaining with LC(1-30) antibody demonstrated a progressive increase in expression of mature TGF-beta1 protein by hepatocytes over the 5 week feeding period. The overexpression of TGF-beta1 may be causally related to the prominent apoptosis and fibrosis seen with FB1-induced liver injury. Increased expression of c-myc may be involved in the cancer promoting effects of FB1.


Subject(s)
Carboxylic Acids/adverse effects , Carcinogens, Environmental/adverse effects , Fumonisins , Fusarium/chemistry , Liver/drug effects , Animals , Carboxylic Acids/administration & dosage , Carcinogens, Environmental/administration & dosage , Desmin/analysis , Diet , Gene Expression/drug effects , Glutathione S-Transferase pi , Glutathione Transferase/analysis , Hepatocyte Growth Factor/genetics , Immunohistochemistry , Isoenzymes/analysis , Liver/metabolism , Liver/pathology , Male , Mycotoxins/administration & dosage , Mycotoxins/adverse effects , Proto-Oncogene Proteins c-myc/genetics , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Rats , Rats, Inbred F344 , Transforming Growth Factor alpha/genetics , Transforming Growth Factor beta/analysis , Transforming Growth Factor beta/genetics , alpha-Fetoproteins/genetics
13.
Biochim Biophys Acta ; 1427(1): 82-91, 1999 Mar 14.
Article in English | MEDLINE | ID: mdl-10082989

ABSTRACT

A fibrinogenase (Ba100) with an apparent molecular mass of 100 kDa under non-reducing conditions and a pI of 5.4 was purified from the venom of the African puff adder (Bitis arietans) by fibrinogen affinity chromatography. Under reducing conditions the protease dissociates into subunits of 21 kDa and 16 kDa. N-Terminal amino acid sequencing showed these two chains to have 66.7% homology and homology to C-type lectins. The fibrinogenase activity of Ba100 cleaves the Aalpha and Bbeta chain of fibrinogen rendering the molecule unable to polymerise into fibrin clots. Ba100 inhibited platelet aggregation in platelet rich plasma, and clot formation in whole blood, in a concentration dependent manner.


Subject(s)
Anticoagulants/chemistry , Fibrinogen/chemistry , Metalloendopeptidases/chemistry , Platelet Aggregation Inhibitors/chemistry , Viper Venoms/chemistry , Viperidae , Amino Acid Sequence , Animals , Anticoagulants/isolation & purification , Fibrin Fibrinogen Degradation Products/analysis , Metalloendopeptidases/isolation & purification , Molecular Sequence Data , Molecular Weight , Platelet Aggregation Inhibitors/isolation & purification , Sequence Alignment , Thrombelastography
14.
Cancer Lett ; 146(2): 207-15, 1999 Nov 15.
Article in English | MEDLINE | ID: mdl-10656628

ABSTRACT

The present study was performed to determine whether excess hepatic iron modulates the cancer-initiating and promoting properties of FB1. Thirty-eight male F344 rats were divided into four dietary treatment groups: (i) control diet (AIN, n = 8); (ii) FB1 250 mg/kg diet (FB1, n = 10); (iii) 1-2% carbonyl iron (CI, n = 10); or (iv) FB1 plus iron loading (FB1/CI, n = 10) for 5 weeks (2 x 2 factorial design). Hepatic iron concentrations in iron-loaded animals at 5 weeks were 444 +/- 56 (CI) and 479 +/- 80 micromol/g dry weight (FB1/CI) (mean +/- SEM). All the FB1-fed rats, in the presence or absence of CI, developed a toxic hepatitis with a 4-fold rise in serum alanine transaminase (ALT) levels. FB1 appeared to augment iron-induced hepatic lipid peroxidation, as measured by the generation of thiobarbituric acid reacting substances (TBARS) in liver homogenates (P < 0.0001). Morphometric analysis showed that FB1 caused a significantly greater mean +/- SEM number of 'enzyme-altered' foci and nodules per cm2 (5.34 +/- 1.42 vs. 1.50 +/- 0.52, P < 0.05), as well as a greater area (%) of liver occupied by foci and nodules (0.33 +/- 0.12% vs. 0.05 +/- 0.03%, P < 0.001), compared with FB1/CI. The addition of FB1 to dietary iron loading caused a shift in distribution of iron from hepatocytes to Kupffer cells, probably due to phagocytosis of necrotic iron-loaded hepatocytes. In conclusion, (i) FB1 appears to cause toxicity in the liver independently from effects on lipid peroxidation; (ii) FB1 has a potentiating effect on iron-induced lipid peroxidation; and (iii) dietary iron loading appears to protect against the cancer promoting properties of FB1, possibly due to a stimulatory effect of iron on hepatocyte regeneration.


Subject(s)
Carboxylic Acids/toxicity , Carcinogens, Environmental/toxicity , Fumonisins , Iron Overload/physiopathology , Liver Neoplasms, Experimental/prevention & control , Animals , Glutathione S-Transferase pi , Glutathione Transferase/metabolism , Isoenzymes/metabolism , Lipid Peroxidation , Liver/metabolism , Liver/pathology , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/pathology , Male , Organ Size , Rats , Rats, Inbred F344 , Weight Gain
15.
Hum Mutat ; 12(6): 403-7, 1998.
Article in English | MEDLINE | ID: mdl-9829909

ABSTRACT

Variegate porphyria is an autosomal dominant disorder of haem metabolism resulting from a partial decrease in protoporphyrinogen oxidase activity. Variegate porphyria is highly prevalent in South Africa, the result of a founder effect now confirmed genetically as a single point mutation (R59W) which has been described in nearly all South African variegate porphyria patients studied. Only two other mutations (H20P, R168C) have been reported in South Africa. We utilised simultaneous, single-stranded conformational polymorphism and heteroduplex analysis, and direct sequencing to identify a further mutation; a 2 bp deletion in exon 6 which results in a premature stop codon 11 codons downstream from the mutation and is the first reported deletion in the protoporphyrinogen oxidase gene in a South African family. The familial segregation of this mutation strongly suggests that it is the disease causing mutation for variegate porphyria in this family. This further evidence for allelic heterogeneity limits the utility of tests for the R59W mutation in the diagnosis of variegate porphyria in South Africa.


Subject(s)
Nucleic Acid Heteroduplexes/analysis , Oxidoreductases Acting on CH-CH Group Donors , Oxidoreductases/genetics , Porphyrias, Hepatic/genetics , Sequence Deletion/genetics , Adult , Blotting, Southern , DNA/blood , Female , Flavoproteins , Humans , Male , Mitochondrial Proteins , Molecular Sequence Data , Pedigree , Polymerase Chain Reaction/methods , Polymorphism, Single-Stranded Conformational , Protoporphyrinogen Oxidase , South Africa
16.
Arch Biochem Biophys ; 358(2): 251-6, 1998 Oct 15.
Article in English | MEDLINE | ID: mdl-9784236

ABSTRACT

The previously cloned and expressed protoporphyrinogen oxidase from Bacillus subtilis has been purified to homogeneity by Ni2+ affinity chromatography using a His6 tag and characterized. The enzyme has a molecular weight of approximately 56,000 daltons, a pI of 7.5, a pH optimum (protoporphyrinogen) of 8.7, and a noncovalently bound flavine adenine dinucleotide cofactor. The Michaelis constants (Km) for protoporphyrinogen-IX, coproporphyrinogen-III, and mesoporphyrinogen-IX are 1.0, 5.29, and 4.92 microM, respectively. Polyclonal antibody to B. subtilis protoporphyrinogen oxidase demonstrated weak cross-reactivity with both human and Myxococcus xanthus protoporphyrinogen oxidase. B. subtilis protoporphyrinogen oxidase is not inhibited by the diphenyl ether herbicide acifluorfen at 100 microM and is weakly inhibited by methylacifluorfen at the same concentration. Bilirubin, biliverdin, and hemin are all competitive inhibitors of this enzyme.


Subject(s)
Bacillus subtilis/enzymology , Oxidoreductases Acting on CH-CH Group Donors , Oxidoreductases/isolation & purification , Aerobiosis , Cloning, Molecular , Enzyme Inhibitors/pharmacology , Isoelectric Focusing , Kinetics , Oxidoreductases/antagonists & inhibitors , Oxidoreductases/genetics , Protoporphyrinogen Oxidase
17.
J Hepatol ; 29(3): 450-4, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9764993

ABSTRACT

BACKGROUND/AIMS: Ductal plate and bile duct cells in developing human liver express haematopoietic stem cell markers, such as c-kit and CD34, in association with cytokeratin markers CAM 5.2 and CK 18. The identification of such ductal plate cells as likely progenitors for both bile duct epithelial cells and hepatocytes and their possible reappearance as oval cells in the regenerating liver have generated much interest in their pluripotential capacities. This study aimed to isolate cells from human fetal liver that co-express haematopoietic stem cell and epithelial cell markers. METHODS: Human fetal liver was harvested following legal termination of pregnancy at week 14-22. CD34+ mononuclear cells were isolated from liver cell suspensions with immunomagnetic beads. Immunofluorescent staining, using anticytokeratin CAM 5.2 against CK 8 and 18, was performed on permeabilised CD34+ cells for flow cytometry and fluorescent microscopy. CD34+ cells were also stained for other stem cell markers (HLA-DR, c-kit) and committed haematopoietic cell markers (CD33, CD38). RESULTS: Approximately 0.9% (range 0.07-4.0%) of the mononuclear cells isolated were CD34+ cells. The number of mononuclear cells isolated correlated with fetal liver weight (r=0.508). About 3-8% of these CD34+ cells stained positively for CAM 5.2. In addition, CD34+ cells were positive for HLA-DR, but only a small percentage was positive for c-kit. Staining for the committed haematological markers, CD33 and CD38, was consistently negative. CONCLUSIONS: This study describes an immunoaffinity method for the enrichment from human fetal liver of cells that co-express haematopoietic stem cell and epithelial cell markers. Such cellular subsets may correspond to pluripotential ductal plate and bile duct cells.


Subject(s)
Antigens, CD34/analysis , Hematopoietic Stem Cells/immunology , Keratins/analysis , Liver/embryology , Biomarkers/chemistry , Embryonic and Fetal Development/physiology , Epithelial Cells/chemistry , Female , Flow Cytometry , Humans , Immunomagnetic Separation , Liver/cytology , Liver/physiology , Microscopy, Fluorescence , Pregnancy , Reproducibility of Results
18.
Blood Coagul Fibrinolysis ; 9(4): 307-13, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9690801

ABSTRACT

The cellular components of the blood, which become associated with fibrin through specific cellular adhesive processes, play a significant role in the breakdown of fibrin. Fibrinolysis by neutrophil elastase and cathepsin G occurs in a manner distinct from that produced by plasmin. This study demonstrates that neutrophil lysosomal enzyme activity further degrades the end products of plasmic fibrin degradation into low-molecular-weight material, followed by reassembly of higher-molecular-weight products in a process dependent on calcium and factor XIII. Although one of the reformed products has a similar molecular weight to D-dimer and is recognized by a monoclonal antibody raised against D-dimer, its isoelectric point indicates it to be distinctly different from plasmin-derived D-dimer. Processing of the end products of plasmic fibrin degradation by neutrophils may have the potential for modulating the immune response as well as compromising the predictive value of tests measuring D-dimer.


Subject(s)
Fibrin Fibrinogen Degradation Products/chemistry , Fibrin Fibrinogen Degradation Products/metabolism , Fibrinolysin/metabolism , Lysosomes/enzymology , Neutrophils/enzymology , Neutrophils/ultrastructure , Antibodies, Monoclonal/analysis , Electrophoresis, Gel, Two-Dimensional , Electrophoresis, Polyacrylamide Gel , Enzyme Inhibitors/pharmacology , Fibrin/chemistry , Fibrin Fibrinogen Degradation Products/drug effects , Fibrin Fibrinogen Degradation Products/immunology , Humans , Iodine Radioisotopes , Isoelectric Point , Lysosomes/drug effects , Molecular Weight , Reducing Agents/pharmacology , Sodium Dodecyl Sulfate , Spermidine/pharmacology , Spermine/pharmacology , Time Factors
20.
Semin Liver Dis ; 18(1): 33-41, 1998.
Article in English | MEDLINE | ID: mdl-9516676

ABSTRACT

Variegate porphyria is an autosomal dominant inherited trait resulting in decreased activity of protoporphyrinogen oxidase. It is characterized clinically by photosensitive skin disease and a propensity to acute neurovisceral crises. The disease is found worldwide but has an exceptionally high frequency in South Africa. The gene for human protoporphyrinogen oxidase has been identified and sequenced, and several mutations in the protoporphyrinogen oxidase gene sequence have been identified. In South Africa, fewer patients now present with acute attacks, leaving a greater proportion with skin disease or asymptomatic disease. Acute attacks of variegate porphyria appear to be less easily provoked and to be milder than those associated with acute intermittent porphyria.


Subject(s)
Oxidoreductases Acting on CH-CH Group Donors , Porphyrias, Hepatic , Acute Disease , Flavoproteins , Humans , Mitochondrial Proteins , Mutation , Oxidoreductases/genetics , Polymorphism, Genetic , Porphyrias, Hepatic/diagnosis , Porphyrias, Hepatic/genetics , Protoporphyrinogen Oxidase
SELECTION OF CITATIONS
SEARCH DETAIL